TrialJournal of thrombosis and thrombolysis2012

Atopaxar and its effects on markers of platelet activation and inflammation: results from the LANCELOT CAD program.

Michelle L O'Donoghue et al.PubMed ↗Publisher ↗

No numbers read from the abstract.